TRUST Reproductive Clinic (TRC), affiliated to IMA Hong Kong Medical Group Limited, is located in the Chuang Capital Building in the CBD business district of Cambodia. We are an institution focused on reproductive healthcare, committed to providing you with high quality reproductive healthcare services. Our team has the experience and expertise to help patients achieve their fertility dreams. No matter what kind of reproductive health services you need, we will provide you with care and support to ensure your health and well-being.
The centre uses the most advanced technology and equipment in the industry to ensure the best possible results on your reproductive journey. In cooperation with leading international reproductive medicine institutions, we actively promote technological innovation and constantly introduce the latest scientific advances. The laboratory is equipped with advanced reproductive technology equipment to provide accurate diagnosis and treatment methods, including in vitro fertilization (IVF), egg freezing, sperm freezing, embryo transfer and more.
TRC continues to innovate in the field of assisted reproduction and collaborates with global partners to continuously improve the quality of medical services and technology. We understand the importance of assisted reproductive treatment to our patients, so we treat each patient with a professional and caring attitude, ensuring that they receive comprehensive support and care throughout the treatment process.
The high pregnancy rate is the main reason why the vast majority of patients choose TRC-IVF. TRC IVF Laboratory invests heavily in the research and development and innovation of assisted reproductive technology every year, which is in line with the international update in real time and maintains the current international frontier technology level. In the TRC-IVF laboratory, more than 200 kinds of genetic diseases of the human body can be detected at the same time through genetic screening and diagnostic technology, and the detection of genetic diseases is more comprehensive and perfect, and the implantation rate of screened high-quality embryos after transfer can be reached
More than 85%, providing more protection for the realization of the fertility dreams of many families.
Through PGD technology, we can diagnose whether there are related genetic pathogenic factors at the genetic level in the individual to be transplanted embryos, so as to ensure the quality of the transplanted embryos. PGD technology allows us to rule out up to 200 genetic diseases. PGD technology is like an early "birth test" before embryo implantation, which can greatly reduce the risk of genetic diseases in the baby and improve the chances of successful pregnancy.
Through PGS technology, we can conduct a detailed analysis of the 23 pairs of chromosomes of the embryo to determine whether there are structural and numerical defects in its chromosomes, ensure the quality of the embryo, improve the probability of conception, and reduce the possibility of abortion or fetal deformity.